Results 71 to 80 of about 4,765 (219)

Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study

British Journal of Haematology, Volume 208, Issue 6, Page 2059-2068, June 2026.
Renal dysfunction represents a possible underrecognized complication of symptomatic WM; this condition correlates with adverse global and disease‐specific clinical outcomes. Summary The prognostic significance of impaired renal function in Waldenström macroglobulinaemia (WM) remains poorly defined.
Nicolò Danesin, Francesco Autore, Anna Maria Frustaci, Gianmarco Favrin, Emanuele Cencini, Alessandro Noto, Irene Dogliotti, Jacopo Olivieri, Marcello Riva, Isacco Ferrarini, Anna Maria Barbui, Sara Steffanoni, Dario Marino, Benedetta Puccini, Piero Maria Stefani, Rita Rizzi, Michele Merli, Angela Ferrari, Stefano Luminari, Carlo Visco, Livio Trentin, Andrea Visentin, Annarita Conconi, Simone Ferrero, Marzia Varettoni, Alessandra Tedeschi, Luca Laurenti, Francesco Piazza   +27 more
wiley   +1 more source

Waldenström Macroglobulinemia Mimicking A Primary Lung Carcinoma [PDF]

Waldenström macroglobulinemia (WM) is a rare hematological disease that accounts for 1-2% of non-Hodgkin lymphomas. WM is a variant of lymphoplasmocytic lymphoma and is characterized by bone marrow involvement as well as immunoglobulin M monoclonal ...
Nalan Akyürek, Merve Şatır Türk, Tuğba Körpeoğlu, Ali Çelik, Irmak Akarsu, Elgun Valiyev, Muhammet Sayan   +6 more
core   +1 more source

Serum ß2-Microglobulin lin Patients with Monoclonal Gammopathies

The International Journal of Biological Markers, 1987
Beta-2-microglobulin concentrations were determined in serum samples from 45 patients with benign and malignant monoclonal gammopathies. In the group of patients suffering from multiple myeloma or Waldenström macroglobulinemia the mean β2-microglobulin ...
Samuele Di Giovanni, Gaetano Valentini, Emma Ravazzolo, Paolo Carducci, Paolo Giallonardo, Camillo Maschio   +5 more
doaj   +1 more source

Macroglobulinemia de Waldenström com hemorragia intra-ocular Waldenström's macroglobulinaemia with intraocular hemorrhage

Revista Brasileira de Hematologia e Hemoterapia, 2006
O objetivo deste trabalho é relatar um caso de macroglobulinemia de Waldenström com envolvimento retiniano e da circulação coroidiana, com boa resposta ao tratamento. O desenho é um caso controle intervencional. Um homem de 47 anos foi encaminhado para o
João J. Nassaralla Júnior, Maria do Rosário F. Roberti   +1 more
doaj   +1 more source

Neoplasm Adverse Events Associated With Anti‐Type 2 Biologics: An FAERS Database Pharmacovigilance Analysis Study

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Biologics targeting Type 2 immune responses, such as omalizumab (anti‐IgE), dupilumab (anti‐interleukin‐4 receptor alpha, anti‐IL‐4Rα), benralizumab (anti‐IL‐5R), reslizumab, and mepolizumab (anti‐IL‐5), are increasingly used clinically.
Wen Lyu, Rui Xu, Lin Chen, Wenbin Lei, Changhui Chen, Jiaqi Liao, Xingyu Lin, Renqiang Ma, Weiping Wen, Hang Li   +9 more
wiley   +1 more source

Zanubrutinib Combined With Rituximab in the Treatment of Bing‐Neel Syndrome: A Case Report

Clinical Case Reports
Bing‐Neel syndrome (BNS) is a rare complication of Waldenström macroglobulinemia, a condition with low incidence in clinical practice and prone to misdiagnosis.
Rongyao Zhang, Juan Chang, Yanqun Shen, Ping Hu, Lulu Zhang   +4 more
doaj   +1 more source

Comparative Analysis of Four Matrix Dilution Methods for Eliminating IgM Paraprotein Interference in Prealbumin and Uric Acid Assays: Based on Two Case Reports

Journal of Clinical Laboratory Analysis, Volume 40, Issue 9, May 2026.
IgM paraproteins can cause significant interference in prealbumin (PA) and uric acid (UA) measurements, leading to falsely abnormal results. We systematically compared four dilution methods to eliminate this interference. Dilution with the PA reagent (containing PEG) effectively restored accurate PA results.
Xiaowei Chi, Zihan Liu, Weifang Liu, Huihui Jiang, Denglu Zhang   +4 more
wiley   +1 more source

Population Pharmacokinetic Modeling and Exposure‐Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 5, May 2026.
ABSTRACT Nemtabrutinib is a Bruton's tyrosine kinase (BTK) inhibitor under clinical investigation in patients with hematologic malignancies, including chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL). Nemtabrutinib plasma concentration data from 578 patients enrolled in phase 1 and 2 clinical studies, treated with doses from 5 to ...
Chiara C. Kemal, Thijs J. Zweers, Elke H. J. Krekels, Manash S. Chatterjee   +3 more
wiley   +1 more source

Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease

, 2011
The combination of fludarabine, cyclophosphamide, and rituximab (FCR) has produced promising results in chronic lymphocytic leukemia and other lymphoproliferative disorders.
Carlo Visco, Benevolo, Giulia, Mario Lazzarino, Meneghini, Vittorio, Nichelatti, Michele, Zinzani, Pier L, Visco, Carlo, Pioltelli, Pietro, Battista, Marta L, Sacchi, Stefano, Pietro Pioltelli, Marzia Varettoni, Enrica Morra, Giulia Benevolo, Morra, Enrica, Alessandra Tedeschi, Zaja, Francesco, Francesco Zaja, Marta L. Battista, Ricci, Francesca, Stefano Sacchi, Michele Nichelatti, Vittorio Meneghini, Varettoni, Marzia, Pier L. Zinzani, Francesca Ricci, Lazzarino, Mario, Umbero Vitolo, Tedeschi, Alessandra, Vitolo, Umbero   +29 more
core   +1 more source

A Case of Bing–Neel Syndrome Successfully Treated with Ibrutinib

Case Reports in Hematology, 2018
Bing–Neel syndrome is a rare manifestation of Waldenström macroglobulinemia characterized by lymphoplasmacytic cells’ infiltration into the central nervous system.
Daniel S. O’Neil, Mark A. Francescone, Karen Khan, Alobeid Bachir, Owen A. O’Connor, Ahmed Sawas   +5 more
doaj   +1 more source